SCHEMBL9305239

SCHEMBL9305239

CCC1=C(N2CCOCC2)c2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 2/20 0.46
▸ NPC1 O15118 4/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ CHRM2 P08172 1/20 0.42
▸ CHRM4 P08173 1/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ CHRM1 P11229 1/20 0.42
▸ CHRM3 P20309 1/20 0.42
▸ MAPT P10636 6/20 0.41
▸ L3MBTL1 Q9Y468 5/20 0.41
▸ LMNA P02545 4/20 0.41
▸ NSD2 O96028 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ AR P10275 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27518334 0.76 HSD11B1 (0.45) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL18689383 0.69 HRH1 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7622505 0.67 HRH1 (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL10446509 0.67 TDP2 (0.73) TDP2NPC1SMN1; SMN2RAB9AMAPK1
SCHEMBL10386402 0.67 NPC1 (0.58) NPC1SMN1; SMN2RAB9AMAPK1TP53
SCHEMBL6509065 0.66 PKM (0.60) NPC1SMN1; SMN2RAB9APKMMAPT
SCHEMBL28445132 0.66 HRH1 (0.35) TSHRCHRM2CHRM4CHRM5CHRM1
SCHEMBL9424119 0.65 LMNA (0.62) NPC1SMN1; SMN2RAB9ATSHRPKM
SCHEMBL19628266 0.65 APAF1 (0.64) TDP2NPC1SMN1; SMN2RAB9AMAPK1
Ammonia Solution, Strong SCHEMBL28335510 0.65 PKM (0.58) NPC1SMN1; SMN2RAB9APKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5292736-A Morpholinoalkylindenes as antiglaucoma agents STERLING WINTHROP INC. (US) 1994-03-08 — — US disclosed
Send feedback